Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab
Concomitant medications may alter the effect of biological therapy in inflammatory bowel disease. The aim was to investigate the effect of proton pump inhibitors on remission rates in patients with inflammatory bowel disease treated with the gut-selective vedolizumab. Patients from the Hungarian nat...
Elmentve itt :
Szerzők: |
Szemes Kata Farkas Nelli Sipos Zoltan Bor Renáta Fábián Anna Szepes Zoltán Farkas Klaudia Molnár Tamás Schafer Eszter Szamosi Tamas Salamon Agnes Vincze Aron Sarlos Patricia |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2024
|
Sorozat: | BIOMEDICINES
12 No. 1 |
Tárgyszavak: | |
doi: | 10.3390/biomedicines12010158 |
mtmt: | 34509107 |
Online Access: | http://publicatio.bibl.u-szeged.hu/29333 |
Hasonló tételek
-
Use of Proton Pump Inhibitors in Hungary Mixed-Method Study to Reveal Scale and Characteristics /
Szerző: Matuz Mária, et al.
Megjelent: (2020) -
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study
Szerző: Bor Renáta, et al.
Megjelent: (2020) -
Efflux pumps of Gram-negative bacteria what they do, how they do it with what and how to deal with them /
Szerző: Amaral Leonard, et al.
Megjelent: (2014) -
Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori
Szerző: Spengler Gabriella, et al.
Megjelent: (2004) -
Selenocompounds as Novel Antibacterial Agents and Bacterial Efflux Pump Inhibitors
Szerző: Mosolygó Tímea, et al.
Megjelent: (2019)